Latest Content

Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinic workflows, safety checks, and at-home dosing potential for on-body isatuximab.

Solid tumor history, cardiopulmonary symptom burden, and age-dependent chemo intensity predicted 30-day readmission or death after AML induction.

At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.

APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.

For Gynecologic Cancer Awareness Month, Amy Schultz, RN, details symptom identification, barrier mitigation, and caregiver support in oncology care.

At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.

Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.

Vanderbilt APPs discuss PSA screening, multidisciplinary care, toxicity management, and genetic testing for Prostate Cancer Awareness Month.

Take our quick survey to help Oncology Nursing News improve how we deliver updates across web, video, email, social media, and podcasts.

Oncology nurse April Fowler shares her personal stage 4 cancer journey, reflecting on clinical empathy, patient advocacy, and oncology endurance.

Dr. Jason Konner discusses psilocybin, clinician burnout, CIPN prevention, and safety protocols for oncology nurses and care teams in cancer care.

Non-CME PER® Podcast

FDA approves belzutifan with lenvatinib for advanced clear cell RCC after PD-1/PD-L1 inhibitor failure. Review LITESPARK-011 data and nursing takeaways.